Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Multicenter study finds AMD patients can benefit from cataract surgery

Multicenter study finds AMD patients can benefit from cataract surgery

Combination of inhibitor and antioxidants may help prevent diabetes complications

Combination of inhibitor and antioxidants may help prevent diabetes complications

Annual dilated eye exam helps prevent vision loss in people with diabetes

Annual dilated eye exam helps prevent vision loss in people with diabetes

CWRU grants licensing agreement to Bioptigen for FDOCT technology

CWRU grants licensing agreement to Bioptigen for FDOCT technology

AAO-PAAO meeting discusses tougher challenges of treating premature babies' vision

AAO-PAAO meeting discusses tougher challenges of treating premature babies' vision

Diabetics who are nearsighted may be less susceptible to diabetic retinopathy

Diabetics who are nearsighted may be less susceptible to diabetic retinopathy

Saving sight in premature babies: The past, present and future of ROP treatment

Saving sight in premature babies: The past, present and future of ROP treatment

Study shows diabetics who are nearsighted may be less susceptible to diabetic retinopathy

Study shows diabetics who are nearsighted may be less susceptible to diabetic retinopathy

NicOx reports financial results for the first nine months of 2009

NicOx reports financial results for the first nine months of 2009

Electronic eye implant mimics human retina; restores partial vision

Electronic eye implant mimics human retina; restores partial vision

Auxano point-of-care indicator system for dry eye syndrome

Auxano point-of-care indicator system for dry eye syndrome

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

ThromboGenics presents Phase IIa microplasmin intravitreal injection trial results at the ASRS conference

ThromboGenics presents Phase IIa microplasmin intravitreal injection trial results at the ASRS conference

Study finds that visual impairment in T1D patients may be decreasing

Study finds that visual impairment in T1D patients may be decreasing

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

Alimera Sciences starts pilot study of Iluvien intravitreal insert

Alimera Sciences starts pilot study of Iluvien intravitreal insert

Sight for Life Foundation offers free vision care

Sight for Life Foundation offers free vision care

New technique found that may prevent vision loss

New technique found that may prevent vision loss

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Stemedica files patent application for diabetic retinopathy treatment

Stemedica files patent application for diabetic retinopathy treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.